What evidence gaps are holding back bio-based polymers?

Do bio-based polymers actually recycle well? The evidence says we don't know yet.

A major gap is the lack of real-world recycling data for bio-based polymers. One study tested two fossil-based polymers (HDPE and PET) and two bio-based ones (PLA and PHB) through multiple recycling cycles, measuring actual changes in mechanical, processing, and optical properties. The results showed that the standard 'economic substitutability' method used by the European Commission gave very different results from the real technical quality changes. HDPE (a fossil-based plastic) kept its quality far better than any bio-based polymer tested [4]. This means current policy and industry assumptions about bio-based plastics being 'circular' may be wrong, and we need a harmonized testing method for all polymers.

Another review of the entire bio-based polymer value chain confirms that recycling technologies and infrastructure are underdeveloped, and that bio-based polymers often fail to meet product requirements after recycling [1]. A third review adds that improving the recycling process and reusability of biodegradable biobased polymers is a key challenge that hasn't been solved [3]. So the evidence gap isn't just about missing data—it's that the data we do have suggests bio-based polymers may not be as recyclable as we hoped.

We don't know how toxic bioplastics are when they break down in the environment.

A critical evidence gap is the near-total absence of standard toxicity thresholds for bioplastics. One review of bioplastic degradation and ecotoxicity found that most toxicological studies do not include the LC50 (lethal concentration for 50% of test organisms) or LD50 (lethal dose for 50% of test organisms) threshold, which are the standard metrics for comparing toxicity across materials [5]. Without these numbers, it's impossible to say whether a bioplastic is safer than conventional plastic when it degrades into micro-nano plastics, monomers, and oligomers. The same review notes that these degradation products are released in different ecosystems, but their toxicity is poorly understood.

Another review on biodegradable biobased polymers points out that environmental limitations on biodegradation rates—like temperature, humidity, and microbial activity—are not well characterized, meaning a bioplastic that degrades quickly in a lab might persist for years in a cold, dry landfill [3]. This gap directly undermines claims that bioplastics are 'environmentally friendly.'

Why can't we just make more bio-based polymers? The evidence shows cost and scalability are still unsolved.

Multiple reviews converge on the same conclusion: bio-based polymers are not yet cost-competitive with conventional plastics, and scaling up production faces major hurdles. One expert survey from a 2022 international symposium identified four key challenge areas: sustainable feedstocks, efficient production and downstream processes, a non-level playing field in life-cycle assessment (LCA) compared to fossil plastics, and underdeveloped policy frameworks [1]. Another review provides a techno-commercial analysis showing that cost, production capabilities, and practicality are the limiting factors in commercialization [3].

A systematic review of food packaging innovations found that 62.5% of studies focused on developing active and biodegradable packaging materials, but the same review concluded that 'research gaps remain in scaling these technologies for industrial application' [2]. A separate review on lignocellulosic biomass (a key feedstock for bio-based polymers) explicitly states that 'challenges and transformative opportunities in improving the scalability and bioconversion process' remain unresolved [6]. Even when promising materials like PLA-based aqueous dispersions for barrier packaging are developed, the studies are often at lab scale, and scaling to pilot production is a stated objective, not a solved problem [7].

Finally, a review on bio-based polymers for pharmaceuticals notes that some properties—like melt strength, impact strength, thermal stability, and permeability—still don't meet end-use application demands, which limits their commercial potential [8]. Together, these studies paint a clear picture: the evidence gaps are not just about missing data, but about fundamental engineering and economic challenges that haven't been overcome.

About These Sources

This answer is built on 8 peer-reviewed studies — published from 2022 to 2026, 7 from 2024 or later, 3 in Q1 journals, collectively cited 212 times — selected as the most relevant from 10 studies that passed quality screening, drawn from 64 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions